Ondryášová H, Koudeláková V, Hajdúch M
Laboratoř experimentální medicíny, Ústav molekulární a translační medicíny, LF UP a FN, Olomouc.
Ceska Gynekol. 2013 Jun;78(3):289-94.
To describe the possibility of detection of HPV DNA in cervical cancer.
Review.
Institute of Molecular and Translational Medicine, Laboratory of Experimental Medicine, Palacky University and University Hospital Olomouc.
Human papillomavirus (HPV) is the cause of many cancers, especially cervical cancer. Current cervical cancer screening is based on cytological examination, which is followed by HPV DNA diagnostics only in cases with abnormal results of uncertain significance. Methods used for HPV detection are often based on PCR reaction followed by genotyping (complete or partial). HPV DNA diagnostics isn´t currently included into the primary cervical cancer screening in the Czech Republic although it has higher sensitivity than cytology.
Inclusion of HPV DNA testing into the primary cervical cancer screening would significantly increase its sensitivity and thus would help to reduce the morbidity and mortality of this disease in Czech population.
描述在宫颈癌中检测人乳头瘤病毒(HPV)DNA的可能性。
综述。
帕拉茨基大学分子与转化医学研究所、实验医学实验室以及奥洛穆茨大学医院。
人乳头瘤病毒(HPV)是多种癌症的病因,尤其是宫颈癌。目前的宫颈癌筛查基于细胞学检查,只有在结果意义不确定异常的情况下才会进行HPV DNA诊断。用于HPV检测的方法通常基于PCR反应及随后的基因分型(完全或部分)。尽管HPV DNA诊断比细胞学检查具有更高的灵敏度,但目前在捷克共和国它并未被纳入原发性宫颈癌筛查。
将HPV DNA检测纳入原发性宫颈癌筛查将显著提高其灵敏度,从而有助于降低捷克人群中该疾病的发病率和死亡率。